Departamento de Bioquímica, Universidad Complutense, Madrid, Spain.
Biophys J. 2010 Nov 17;99(10):3290-9. doi: 10.1016/j.bpj.2010.09.039.
The hydrophobic proteins SP-B and SP-C are essential for pulmonary surfactant function, even though they are a relatively minor component (<2% of surfactant dry mass). Despite countless studies, their specific differential action and their possible concerted role to optimize the surface properties of surfactant films have not been completely elucidated. Under conditions kept as physiologically relevant as possible, we tested the surface activity and mechanical stability of several surfactant films of varying protein composition in vitro using a captive bubble surfactometer and a novel (to our knowledge) stability test. We found that in the naturally derived surfactant lipid mixtures, surfactant protein SP-B promoted film formation and reextension to lower surface tensions than SP-C, and in particular played a vital role in sustaining film stability at the most compressed states, whereas SP-C produced no stabilization. Preparations containing both proteins together revealed a slight combined effect in enhancing film formation. These results provide a qualitative and quantitative framework for the development of future synthetic therapeutic surfactants, and illustrate the crucial need to include SP-B or an efficient SP-B analog for optimal function.
疏水蛋白 SP-B 和 SP-C 对肺表面活性物质的功能至关重要,尽管它们在表面活性物质中只占相对较小的比例(<2%)。尽管进行了无数的研究,但它们的具体差异作用及其可能协同优化表面活性物质膜表面性质的作用仍未完全阐明。在尽可能保持生理相关的条件下,我们使用俘获气泡表面张力仪和一种新颖的(据我们所知)稳定性测试,在体外测试了不同蛋白组成的几种表面活性物质膜的表面活性和机械稳定性。我们发现,在天然衍生的表面活性脂质混合物中,表面活性蛋白 SP-B 促进了膜的形成和再延伸,使表面张力降低到比 SP-C 更低的水平,特别是在最压缩状态下对维持膜的稳定性起着至关重要的作用,而 SP-C 则没有稳定作用。含有这两种蛋白的制剂显示出略微的协同作用,增强了膜的形成。这些结果为未来合成治疗性表面活性物质的发展提供了定性和定量的框架,并说明了包含 SP-B 或高效 SP-B 类似物以获得最佳功能的迫切需要。